Benchmarking disclosure performance Brian Kuzich, Senior Solution Consultant, and Sahil Khatter, Principal Project Manager, held an interactive session on ways companies benchmark disclosure performance
In: Sibirny A (ed) Biotechnology of yeasts and filamentous fungi
Regulation of cisplatin resistance in bladder cancer by epigenetic mechanisms
Journal of Vascular Surgery: Venous and Lymphatic Disorders
Therefore, despite being only a partial effector of carcinogenesis, CBS belongs to a panel of intervening players, including NF-B, KRAS, p53 and Wnt components, that contribute to metabolic rewiring and increased proliferative and invasive potential
Novo Nordisk developed it as a long-acting version of the naturally occurring hormone, engineered with specific amino acid substitutions that extend its duration of action from minutes to days